Honorhealth Research Institute
Clinical trials sponsored by Honorhealth Research Institute, explained in plain language.
-
Malaria drug combo shows promise against COVID-19 in early trial
Disease control TerminatedThis phase 2 trial tests whether a combination of atovaquone (an anti-malarial) and azithromycin (an antibiotic) can clear the COVID-19 virus in infected adults. The study enrolls people at high risk for complications, such as those with moderate to severe illness. Participants r…
Phase: PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Experimental cocktail takes on tough pancreatic cancer
Disease control TerminatedThis early-phase trial is testing whether adding two immunotherapy drugs (botensilimab and balstilimab) to a strong chemotherapy mix plus two oral medications (chloroquine and celecoxib) can help people with metastatic pancreatic cancer that hasn't been treated yet. The study inv…
Phase: PHASE1 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC